FDA Grants PMA Approval for LungFX EVLP Device to Assess Donor Lungs Before Transplantation – United Therapeutics
United Therapeutics Corporation announced that the FDA has granted premarket approval (PMA) of the LungFXTM device (LungFX) for use in centralized ex vivo lung perfusion (EVLP), a procedure… read more.
